Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method

According to the predominant theories, soluble amyloid-beta (Aβ) aggregates are the principal neurotoxic agents in Alzheimer’s disease pathology, making them a popular target for the development of therapeutics and diagnostic markers. One of the most commonly used methods for determining the concent...

Full description

Bibliographic Details
Main Authors: Leen Janssen, Frank Sobott, Peter P. De Deyn, Debby Van Dam
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:MethodsX
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221501611500014X
_version_ 1831601046288334848
author Leen Janssen
Frank Sobott
Peter P. De Deyn
Debby Van Dam
author_facet Leen Janssen
Frank Sobott
Peter P. De Deyn
Debby Van Dam
author_sort Leen Janssen
collection DOAJ
description According to the predominant theories, soluble amyloid-beta (Aβ) aggregates are the principal neurotoxic agents in Alzheimer’s disease pathology, making them a popular target for the development of therapeutics and diagnostic markers. One of the most commonly used methods for determining the concentration of Aβ is ELISA. However, ELISA was developed for monomeric proteins and may be ill-suited for detecting aggregates. Therefore, we investigated the effect of aggregation on the ELISA measurement and developed a novel chemical pre-treatment method, designed to disaggregate Aβ peptides, to improve the ELISA measurement of the total Aβ concentration. Synthetic Aβ40 monomers, Aβ42 oligomers and biological samples from mice and humans were subjected to a chemical pre-treatment protocol with: trifluoroacetic acid (TFA), formic acid (FA) or hexafluoroisopropanol (HFIP) prior to ELISA analysis. In our study we have shown that: • Aβ oligomerization leads to epitope masking and steric hindrance and results in an underestimation of the total Aβ content with ELISA. • Chemically pre-treating samples to disaggregate oligomers can (partially) recover the signal loss. • This novel sample pre-treatment method could provide a more accurate ELISA measurement of the total Aβ concentration in samples with a high oligomer content.
first_indexed 2024-12-18T14:55:42Z
format Article
id doaj.art-146904d2ddb84b4a99aee4d295977199
institution Directory Open Access Journal
issn 2215-0161
language English
last_indexed 2024-12-18T14:55:42Z
publishDate 2015-01-01
publisher Elsevier
record_format Article
series MethodsX
spelling doaj.art-146904d2ddb84b4a99aee4d2959771992022-12-21T21:04:03ZengElsevierMethodsX2215-01612015-01-012C11212310.1016/j.mex.2015.02.011Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment methodLeen Janssen0Frank Sobott1Peter P. De Deyn2Debby Van Dam3Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, BelgiumBiomolecular & Analytical Mass Spectrometry and Center for Proteomics (CFP-CeProMa), Department of Chemistry, University of Antwerp, Antwerp, BelgiumLaboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, BelgiumLaboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, BelgiumAccording to the predominant theories, soluble amyloid-beta (Aβ) aggregates are the principal neurotoxic agents in Alzheimer’s disease pathology, making them a popular target for the development of therapeutics and diagnostic markers. One of the most commonly used methods for determining the concentration of Aβ is ELISA. However, ELISA was developed for monomeric proteins and may be ill-suited for detecting aggregates. Therefore, we investigated the effect of aggregation on the ELISA measurement and developed a novel chemical pre-treatment method, designed to disaggregate Aβ peptides, to improve the ELISA measurement of the total Aβ concentration. Synthetic Aβ40 monomers, Aβ42 oligomers and biological samples from mice and humans were subjected to a chemical pre-treatment protocol with: trifluoroacetic acid (TFA), formic acid (FA) or hexafluoroisopropanol (HFIP) prior to ELISA analysis. In our study we have shown that: • Aβ oligomerization leads to epitope masking and steric hindrance and results in an underestimation of the total Aβ content with ELISA. • Chemically pre-treating samples to disaggregate oligomers can (partially) recover the signal loss. • This novel sample pre-treatment method could provide a more accurate ELISA measurement of the total Aβ concentration in samples with a high oligomer content.http://www.sciencedirect.com/science/article/pii/S221501611500014XSample pre-treatment for amyloid-beta ELISA analysis
spellingShingle Leen Janssen
Frank Sobott
Peter P. De Deyn
Debby Van Dam
Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method
MethodsX
Sample pre-treatment for amyloid-beta ELISA analysis
title Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method
title_full Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method
title_fullStr Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method
title_full_unstemmed Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method
title_short Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method
title_sort signal loss due to oligomerization in elisa analysis of amyloid beta can be recovered by a novel sample pre treatment method
topic Sample pre-treatment for amyloid-beta ELISA analysis
url http://www.sciencedirect.com/science/article/pii/S221501611500014X
work_keys_str_mv AT leenjanssen signallossduetooligomerizationinelisaanalysisofamyloidbetacanberecoveredbyanovelsamplepretreatmentmethod
AT franksobott signallossduetooligomerizationinelisaanalysisofamyloidbetacanberecoveredbyanovelsamplepretreatmentmethod
AT peterpdedeyn signallossduetooligomerizationinelisaanalysisofamyloidbetacanberecoveredbyanovelsamplepretreatmentmethod
AT debbyvandam signallossduetooligomerizationinelisaanalysisofamyloidbetacanberecoveredbyanovelsamplepretreatmentmethod